Vanguard Fiduciary Trust’s BioVie BIVI Stock Holding History

Vanguard Fiduciary Trust’s Portfolio BIVI Stock Details BIVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$72.9K	Hold	37,557	–	–	﹤0.01%	3790
2026 Q1	$52.6K	Buy	+37,557	New	+$48.3K	﹤0.01%	3822

Other funds holding BIVI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PTC

Philadelphia Trust Company Philadelphia, Pennsylvania $1.56B AUM 44.46% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

PCM

Prelude Capital Management New York $1.37B AUM 71.69% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

PAP

Persistent Asset Partners Hong Kong $335M AUM 275.57% 1-Year Est. Return

Vanguard Fiduciary Trust's BIVI Position: Q2 2026 in Review

Vanguard Fiduciary Trust held its BioVie (BIVI) position steady in Q2 2026 at 37,557 shares worth $72.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3790.

Vanguard Fiduciary Trust first reported a position in BIVI in Q1 2026 and has held it in 2 quarters since. 34 funds tracked by Wall St. Rank hold BIVI as of Q2 2026.

Vanguard Fiduciary Trust held 37,557 shares of BioVie worth $72.9K as of Q2 2026.
Vanguard Fiduciary Trust left its BioVie share count unchanged in Q2 2026.
BioVie made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #3790 holding.
Vanguard Fiduciary Trust first reported a position in BioVie in Q1 2026 and has held it in 2 quarters since.
34 funds tracked by Wall St. Rank held BioVie as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.